![Mark Robbins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mark Robbins worked as Vice President-Clinical & Regulatory Affairs at DiaMedica Therapeutics, Inc. from 2013 to 2015.
He was also President at Tansna Therapeutics, Inc. and Chief Scientific Officer & EVP Legal Operations at Upsher-Smith Laboratories LLC.
Ehemalige bekannte Positionen von Mark Robbins
| Unternehmen | Position | Ende |
|---|---|---|
Tansna Therapeutics, Inc.
 Tansna Therapeutics, Inc. Medical DistributorsDistribution Services Develops and offers oral drugs to treat epilepsy | Präsident | 01.10.2018 |
| DIAMEDICA THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 20.01.2015 |
Upsher-Smith Laboratories LLC
 Upsher-Smith Laboratories LLC Pharmaceuticals: MajorHealth Technology Manufactures and markets generic pharmaceutical products | Geschäftsführer | 10.01.2013 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Tansna Therapeutics, Inc.
Tansna Therapeutics, Inc. Medical DistributorsDistribution Services Develops and offers oral drugs to treat epilepsy | Distribution Services |
Upsher-Smith Laboratories LLC
Upsher-Smith Laboratories LLC Pharmaceuticals: MajorHealth Technology Manufactures and markets generic pharmaceutical products | Health Technology |
